Company record · IDXX · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories
The principal financial officer who signed Idexx Laboratories's latest annual report is Andrew J. Emerson, verified February 20, 2026.
Roster record
| Officer | Andrew J. Emerson |
|---|---|
| Verified | February 20, 2026 (filing date of the source) |
| Note | The DEF 14A filed 2026-03-27 does not name Andrew J. Emerson near a Chief Financial Officer title; check for a change. An 8-K with Item 5.02 was filed on 2026-03-26, after this 10-K; any CFO change it reports is tracked on the moves record. |
- sec.gov · signature block · “/s/ Andrew J. Emerson Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)”
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.